MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-11-30, CCEL had -$241,929 decrease in cash & cash equivalents over the period. $5,248,131 in free cash flow.

Cash Flow Overview

Change in Cash
-$241,929
Free Cash flow
$5,248,131
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from line of credit
    • Deferred revenue
    • Impairment of public inventory
    • Others
Negative Cash Flow Breakdown
    • Repayment of line of credit
    • Purchases of marketable securiti...
    • Dividends paid
    • Others

Cash Flow
2025-11-30
Net (loss) income
-2,429,385
Depreciation and amortization expense
985,242
Impairment of public inventory
4,358,834
Impairment of investment - tianhe stock
0
Loss on sale of property and equipment
-48,304
Losses (gains) on marketable securities
-806,267
Unrealized gain on interest rate swap contract
0
Compensatory element of stock options
417,101
Provision for doubtful accounts
868,795
Deferred income tax benefit
-2,818,688
Amortization of debt issuance costs
20,822
Amortization of operating lease right-of-use asset
382,876
Accounts receivable
405,881
Prepaid expenses
-63,837
Inventory
-56,190
Other current assets
179,387
Deposits and other assets, net
99,464
Accounts payable
1,000,257
Accrued expenses
-1,531,845
Operating lease liability
-424,701
Other liabilities
0
Deferred revenue
4,359,432
Net cash from operating activities
5,478,606
Purchases of property and equipment
230,475
Sale of property and equipment
115,000
Payment of duke license agreement
0
Proceeds from liquidation of marketable securities
0
Purchases of marketable securities
3,647,764
Sale of marketable securities
2,787,907
Net cash used in investing activities
-975,332
Treasury stock purchases
169,502
Repayments of note payable
147,575
Repayment of line of credit
10,020,000
Proceeds from the exercise of stock options
23,101
Proceeds from line of credit
8,800,000
Dividends paid
3,231,227
Proceeds from swap termination
0
Net cash used in financing activities
-4,745,203
(decrease) increase in cash and cash equivalents
-241,929
Cash and cash equivalents - beginning of period
560,960
Cash and cash equivalents - end of period
319,031
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Deferred revenue$4,359,432 Impairment of publicinventory$4,358,834 Accounts payable$1,000,257 Depreciation andamortization expense$985,242 Provision for doubtfulaccounts$868,795 Losses (gains) onmarketable securities-$806,267 Compensatory element of stockoptions$417,101 Amortization of operatinglease right-of-use...$382,876 Prepaid expenses-$63,837 Inventory-$56,190 Loss on sale ofproperty and equipment-$48,304 Amortization of debt issuancecosts$20,822 Net cash fromoperating activities$5,478,606 Canceled cashflow$7,889,351 (decrease) increase in cashand cash...-$241,929 Canceled cashflow$5,478,606 Proceeds from line ofcredit$8,800,000 Proceeds from theexercise of stock options$23,101 Sale of marketablesecurities$2,787,907 Sale of property andequipment$115,000 Deferred income taxbenefit-$2,818,688 Net (loss) income-$2,429,385 Accrued expenses-$1,531,845 Operating lease liability-$424,701 Accounts receivable$405,881 Other current assets$179,387 Deposits and otherassets, net$99,464 Net cash used infinancing activities-$4,745,203 Canceled cashflow$8,823,101 Net cash used ininvesting activities-$975,332 Canceled cashflow$2,902,907 Repayment of line of credit$10,020,000 Dividends paid$3,231,227 Treasury stock purchases$169,502 Repayments of note payable$147,575 Purchases of marketablesecurities$3,647,764 Purchases of property andequipment$230,475

CRYO CELL INTERNATIONAL INC (CCEL)

CRYO CELL INTERNATIONAL INC (CCEL)